Irma Lee Vazquez-Sanabria

Irma Vazquez-Sanabria practices at Spartanburg Medical Center in Spartanburg, South Carolina, part of Spartanburg Regional Healthcare System.

Irma Vazquez-Sanabria's NPI, 1649421371, was assigned on September 30, 2008. Irma Vazquez-Sanabria holds Illinois license 036151648.

Irma Vazquez-Sanabria's primary practice is Spartanburg Medical Center, at 101 E Wood St, Spartanburg, SC 29303 in Spartanburg County. The practice phone is (864) 560-6554.

Irma Vazquez-Sanabria's primary practice is Spartanburg Medical Center in Spartanburg, South Carolina, part of Spartanburg Regional Healthcare System. Irma Vazquez-Sanabria is also affiliated with Marietta Memorial Hospital. The medical group on file is Medical Group of the Carolinas - Family Medicine - Converse Heights. Dmand AI also links Irma Vazquez-Sanabria to 4 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Irma Vazquez-Sanabria practices, 7 sites in all. Vendor and product names are available with a free account.

Rheumatology is Irma Vazquez-Sanabria's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Irma Vazquez-Sanabria's licenses on file in 2 states: Illinois and South Carolina.

CMS data shows 278 Medicare services from Irma Vazquez-Sanabria across 8 procedure codes in 2024, for 80 Medicare patients. Medicare paid $11,167 for them. Every service was in an office.

CMS counts 80 Medicare patients who saw Irma Vazquez-Sanabria in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have arthritis, and 75% have high blood pressure. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Irma Vazquez-Sanabria's median patient age at 62, with 67% women.

In 2024, Irma Vazquez-Sanabria wrote 1,822 Medicare Part D claims for 292 patients. 87% of them were for generic drugs. CMS names the drug for 1,512 of them, across 32 drugs with 11 or more claims each, at $659,091 in total drug cost. In 2023, CMS named 691 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Irma Vazquez-Sanabria for performance year 2024, reported as part of a group. Irma Vazquez-Sanabria accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Irma Vazquez-Sanabria as offering telehealth.

CMS Open Payments shows 635 general payments to Irma Vazquez-Sanabria from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Janssen Pharmaceuticals, Inc paid the most, $2,252.